Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume 80, Issue 6, Pages 811-820
Publisher
Wiley
Online
2016-10-20
DOI
10.1002/ana.24802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lack of association betweenMC1Rvariants and Parkinson disease in European descent
- (2016) Qinghua Jiang et al. ANNALS OF NEUROLOGY
- Rare variants in MC1R/TUBB3 exon 1 are not associated with Parkinson's disease
- (2016) Oswaldo Lorenzo-Betancor et al. ANNALS OF NEUROLOGY
- Parkin Somatic Mutations Link Melanoma and Parkinson's Disease
- (2016) Lotan Levin et al. Journal of Genetics and Genomics
- Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance
- (2016) Dena G. Hernandez et al. JOURNAL OF NEUROCHEMISTRY
- MC1R variants in Chinese Han patients with sporadic Parkinson's disease
- (2016) Chang-he Shi et al. NEUROBIOLOGY OF AGING
- Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease
- (2016) S.J. Lubbe et al. NEUROBIOLOGY OF AGING
- The Evolution of Genetics: Alzheimer’s and Parkinson’s Diseases
- (2016) Andrew Singleton et al. NEURON
- Genetic analysis of MC1R variants in Chinese Han patients with sporadic Parkinson’s disease
- (2016) Sihan He et al. NEUROSCIENCE LETTERS
- The genomic landscape of cutaneous melanoma
- (2016) Tongwu Zhang et al. Pigment Cell & Melanoma Research
- Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites
- (2016) Andres Binolfi et al. Nature Communications
- Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s disease
- (2016) Qingde Zhou et al. Nature Communications
- Germline MC1R status influences somatic mutation burden in melanoma
- (2016) Carla Daniela Robles-Espinoza et al. Nature Communications
- Whole-Exome Sequencing in Familial Parkinson Disease
- (2016) Janice L. Farlow et al. JAMA Neurology
- Factors in Association Between Parkinson Disease and Risk of Cancer in Taiwan
- (2016) D. Michal Freedman et al. JAMA Oncology
- Associations Between Parkinson Disease and Cancer in US Asian Americans
- (2016) D. Michal Freedman et al. JAMA Oncology
- TheEIF4G1gene and Parkinson's disease
- (2015) H. Deng et al. ACTA NEUROLOGICA SCANDINAVICA
- Is theMC1Rvariant p.R160W associated with Parkinson's?
- (2015) Steven J. Lubbe et al. ANNALS OF NEUROLOGY
- Nonsynonymous variants inMC1Rare rare in Chinese Parkinson disease cases
- (2015) Jia Nee Foo et al. ANNALS OF NEUROLOGY
- TheMC1Rmelanoma risk variant p.R160W is associated with Parkinson disease
- (2015) Gemma Tell-Marti et al. ANNALS OF NEUROLOGY
- DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulatingpink1
- (2015) Raquel Requejo-Aguilar et al. BIOCHEMICAL JOURNAL
- SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex
- (2015) Y. Feng et al. CANCER RESEARCH
- Functions and characteristics of PINK1 and Parkin in cancer
- (2015) Satoru Matsuda Frontiers in Bioscience-Landmark
- Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
- (2015) Matthew H Law et al. NATURE GENETICS
- The tumor suppressor PTEN regulates motor responses to striatal dopamine in normal and Parkinsonian animals
- (2015) Mihaela A. Stavarache et al. NEUROBIOLOGY OF DISEASE
- Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein
- (2015) Nripesh Dhungel et al. NEURON
- A novel homozygous PLA2G6 mutation causes dystonia-parkinsonism
- (2015) M.C. Malaguti et al. PARKINSONISM & RELATED DISORDERS
- Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
- (2015) Nir Ben-Chetrit et al. Science Signaling
- Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
- (2015) Aline Verstraeten et al. TRENDS IN GENETICS
- Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces
- (2015) Asuka Sasaki et al. Scientific Reports
- Higher Frequency of Certain Cancers inLRRK2G2019S Mutation Carriers With Parkinson Disease
- (2015) Ilir Agalliu et al. JAMA Neurology
- Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
- (2015) Nir Ben-Chetrit et al. Science Signaling
- Association Between Parkinson Disease and Risk of Cancer in Taiwan
- (2015) Pei-Ying Lin et al. JAMA Oncology
- The association between Parkinson’s disease and melanoma: a systematic review and meta-analysis
- (2015) Pei Huang et al. Translational Neurodegeneration
- The associations between Parkinson’s disease and cancer: the plot thickens
- (2015) Danielle D. Feng et al. Translational Neurodegeneration
- Local Immunosuppressive Microenvironment Enhances Migration of Melanoma Cells to Lungs in DJ-1 Knockout Mice
- (2015) Chia-Hung Chien et al. PLoS One
- A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues
- (2015) Charlotte Welinder et al. PLoS One
- Risk Prediction Models for Melanoma: A Systematic Review
- (2014) J. A. Usher-Smith et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Oncogenes in melanoma: An update
- (2014) Manfred Kunz EUROPEAN JOURNAL OF CELL BIOLOGY
- MC1R and NR4A receptors in cellular stress and DNA repair: implications for UVR protection
- (2014) Kelvin Yin et al. EXPERIMENTAL DERMATOLOGY
- The link between Parkinson's disease and breast and prostate cancers: A meta-analysis
- (2014) Tengfei Wang INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Somatic Mutation of GRIN2A in Malignant Melanoma Results in Loss of Tumor Suppressor Activity via Aberrant NMDAR Complex Formation
- (2014) Todd D. Prickett et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Melanocortin 1 Receptor (Mc1r) Variants Do Not Account for the Co-occurrence of Parkinson's Disease and Malignant Melanoma
- (2014) Sandra Elincx-Benizri et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- LRRK2 pathobiology in Parkinson's disease
- (2014) Ian Martin et al. JOURNAL OF NEUROCHEMISTRY
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
- (2014) Yongxing Gong et al. NATURE GENETICS
- Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease
- (2014) Jing Dong et al. NEUROBIOLOGY OF AGING
- Pheomelanin-induced oxidative stress: bright and dark chemistry bridging red hair phenotype and melanoma
- (2014) Alessandra Napolitano et al. Pigment Cell & Melanoma Research
- Caffeine Interaction with Glutamate Receptor Gene GRIN2A: Parkinson's Disease in Swedish Population
- (2014) Naomi Yamada-Fowler et al. PLoS One
- Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay
- (2014) Charlotte Welinder et al. PLoS One
- Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson Disease
- (2014) Ismaïl Ahmed et al. PLoS Genetics
- Glutamate Receptor Gene GRIN2A, Coffee, and Parkinson Disease
- (2014) Taye H. Hamza et al. PLoS Genetics
- Genetic Movement Disorders in Patients of Jewish Ancestry
- (2014) Rivka Inzelberg et al. JAMA Neurology
- The Genetics of Melanoma: Recent Advances
- (2013) Victoria K. Hill et al. Annual Review of Genomics and Human Genetics
- Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S
- (2013) Min Liu et al. BIOCHEMISTRY
- Malignant melanoma in early-treated Parkinson's disease: The NET-PD trial
- (2013) Radu Constantinescu et al. MOVEMENT DISORDERS
- Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease
- (2013) K. Nuytemans et al. NEUROLOGY
- Genetics of Parkinson's disease – state of the art, 2013
- (2013) Vincenzo Bonifati PARKINSONISM & RELATED DISORDERS
- The genetics and neuropathology of Parkinson’s disease
- (2012) Henry Houlden et al. ACTA NEUROPATHOLOGICA
- Shared Predispositions of Parkinsonism and Cancer
- (2012) Seth A. Kareus et al. ARCHIVES OF NEUROLOGY
- No Association between Parkinson Disease Alleles and the Risk of Melanoma
- (2012) S. Meng et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Lack of association between cancer history andPARKINgenotype: A family based study inPARKIN/Parkinson's Families
- (2012) Roy N. Alcalay et al. GENES CHROMOSOMES & CANCER
- Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease
- (2012) Kathrine Rugbjerg et al. INTERNATIONAL JOURNAL OF CANCER
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
- (2012) R. Inzelberg et al. NEUROLOGY
- The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
- (2012) Tianhong Pan et al. PLoS One
- LRRK2 in Transcription and Translation Regulation: Relevance for Parkinson’s Disease
- (2012) Véronique Dorval et al. Frontiers in Neurology
- The association between Parkinson's disease and melanoma
- (2011) Tianhong Pan et al. INTERNATIONAL JOURNAL OF CANCER
- High prevalence of malignant melanoma in Israeli patients with Parkinson’s disease
- (2011) R. Inzelberg et al. JOURNAL OF NEURAL TRANSMISSION
- Exome sequencing identifies GRIN2A as frequently mutated in melanoma
- (2011) Xiaomu Wei et al. NATURE GENETICS
- Meta-analysis of the relationship between Parkinson disease and melanoma
- (2011) R. Liu et al. NEUROLOGY
- Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas
- (2011) B. D. Looyenga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee
- (2011) Taye H. Hamza et al. PLoS Genetics
- Frequency of Known Mutations in Early-Onset Parkinson Disease
- (2010) Roy N. Alcalay et al. ARCHIVES OF NEUROLOGY
- Increased Melanoma Risk in Parkinson Disease
- (2010) John M. Bertoni ARCHIVES OF NEUROLOGY
- Parkinson’s disease and cancer risk: a systematic review and meta-analysis
- (2010) Archna Bajaj et al. CANCER CAUSES & CONTROL
- Parkinson Disease and Malignant Melanoma in First-degree Relatives of Patients With Early-onset Melanoma
- (2010) Jørgen H. Olsen et al. EPIDEMIOLOGY
- LRRK2G2019S mutations are associated with an increased cancer risk in Parkinson disease
- (2010) Rachel Saunders-Pullman et al. MOVEMENT DISORDERS
- Common pathogenic pathways in melanoma and Parkinson disease
- (2010) C. Paisan-Ruiz et al. NEUROLOGY
- Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
- (2010) Yasuhiro Matsuo et al. PLoS One
- Catalytic Function of PLA2G6 Is Impaired by Mutations Associated with Infantile Neuroaxonal Dystrophy but Not Dystonia-Parkinsonism
- (2010) Laura A. Engel et al. PLoS One
- Genetic determinants of hair color and parkinson's disease risk
- (2009) Xiang Gao et al. ANNALS OF NEUROLOGY
- MC1R variant alleles and malignant melanoma risk in Israel
- (2009) Gilli Galore-Haskel et al. EUROPEAN JOURNAL OF CANCER
- LRRK2 in Parkinson’s disease: function in cells and neurodegeneration
- (2009) Philip J. Webber et al. FEBS Journal
- Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF- B signaling
- (2009) D. Sha et al. HUMAN MOLECULAR GENETICS
- The particular relationship between Parkinson’s disease and malignancy: a focus on skin cancers
- (2009) Rivka Inzelberg et al. JOURNAL OF NEURAL TRANSMISSION
- The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation
- (2009) Sharon Hassin-Baer et al. JOURNAL OF NEUROLOGY
- Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
- (2009) Deborah Silvera et al. NATURE CELL BIOLOGY
- Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies
- (2009) Selvaraju Veeriah et al. NATURE GENETICS
- Family history of melanoma and Parkinson disease risk
- (2009) X. Gao et al. NEUROLOGY
- Genome-wide associations studies for melanoma and nevi
- (2009) Iwei Yeh et al. Pigment Cell & Melanoma Research
- Characterization of PLA2G6 as a locus for dystonia-parkinsonism
- (2008) Coro Paisan-Ruiz et al. ANNALS OF NEUROLOGY
- Tumorigenesis and neurodegeneration: two sides of the same coin?
- (2008) John F. Staropoli BIOESSAYS
- The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
- (2008) T. Pan et al. BRAIN
- Red hair is the null phenotype of MC1R
- (2008) Kimberley A. Beaumont et al. HUMAN MUTATION
- Pigmentation genes link Parkinson’s disease to melanoma, opening a window on both etiologies
- (2008) Elena Herrero Hernández MEDICAL HYPOTHESES
- Neuroprotective actions of melanocortins: a therapeutic opportunity
- (2008) Anna Catania TRENDS IN NEUROSCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search